4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-006103
CEO sold 523 shares at $87.92 ($45,982)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zovighian Bernard J CEO | 2026-06-17 | Sale 10b5-1 | −523 | $87.92 | $45,982 | 11,516.55 | I: show line 1 in the form |
| Open-market sales · 523 sh · avg $87.92 · $45,982 | |||||||
Loading xslF345X06/doc4.xml…